Follow us on Twitter
twitter icon@FreshPatents


Galactooligosaccharide patents

      

This page is updated frequently with new Galactooligosaccharide-related patent applications.




 Methods for providing sialylated oligosaccharides patent thumbnailMethods for providing sialylated oligosaccharides
The invention relates to a method for providing analogs of human milk oligosaccharides (hmo), in particular oligosaccharides containing terminal sialic acid. The method comprises the steps of: a) providing a source of non-digestible galactooligosaccharides (gos) containing at least two terminally bonded β-linked galactose residues; b) providing a sialic acid donor having (α2-3)-sialylated o-glycans; c) contacting said gos with said sialic acid donor in the presence of an enzyme having trans-sialidase activity in an enzyme reaction mixture; and d) isolating from said enzyme reaction mixture a fraction comprising at least 20 percent by weight of disialylated galactooligosaccharides (di-sia-gos) based on the dry matter..
Rijksuniversiteit Groningen


 Methods of enhancing the gastrointestinal health of a companion animal patent thumbnailMethods of enhancing the gastrointestinal health of a companion animal
Disclosed herein are methods for enhancing the gastrointestinal health of a companion animal, comprising orally administering to the companion animal a composition comprising at least about 0.25% of fermentable fiber by weight of the composition. Further disclosed herein are methods of improving the fecal odor of the feces of a companion animal, comprising orally administering to the companion animal a composition comprising at least about 0.25% of fermentable fiber by weight of the composition.
Mars, Incorporated


 Composition with synbiotics patent thumbnailComposition with synbiotics
Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed.. .
N.v. Nutricia


 Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides patent thumbnailMilk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides
The invention discloses an oligosaccharide mixture derived from cow's milk that can be easily spray dried comprising (a) a soluble oligosaccharide population which is the same as that of soluble oligosaccharides found in cow's milk and (b) β-galactooligosaccharides formed by the action of β-galacotsidase on lactose and the milk oligosaccharides. The mixture having a total monosaccharide content of less than 5% w/v and a lactose:oligosaccharide ratio of less than 20.
Nestec S.a.


 Oral rehydration compositions with galactooligosaccharides patent thumbnailOral rehydration compositions with galactooligosaccharides
The general inventive concepts are directed to compositions and methods for the prevention and treatment of dehydration. Provided herein are oral rehydration formulas (orf) having an acidic ph, and comprising a source of carbohydrate, a source of sodium, a source of citrate, and a source of an oligosaccharide..
Abbott Laboratories


 A preparation  galactooligosaccharides with enhanced galactosyllactose which is a ingredient of mother's milk patent thumbnailA preparation galactooligosaccharides with enhanced galactosyllactose which is a ingredient of mother's milk
The present invention relates to a method of preparing galactooligosaccharides having % a galactosyllactose content of 40 wt % or more.. .
Neo Cremar Co., Ltd.


 Galactooligosaccharide composition for use in preventing or treating cognitive dysfunction and emotional disturbances in neuropsychiatry illnesses or ageing patent thumbnailGalactooligosaccharide composition for use in preventing or treating cognitive dysfunction and emotional disturbances in neuropsychiatry illnesses or ageing
A galactooligosaccharide composition comprising a mixture of disaccharides, trisaccharides, a tetrasaccharide and a pentasaccharide for use in preventing or treating cognitive dysfunction and/or emotional disturbances in neuropsychiatric illnesses or ageing.. .
Clasado Inc


 Fermented nutrition high in lactose with increased iron bioavailability patent thumbnailFermented nutrition high in lactose with increased iron bioavailability
The present invention relates to fermented nutritional compositions comprising high concentration of lactosem such as 6 grams per 100 ml, and optionally non-digestible oligosaccharides, such as galactooligosaccharides or fructooligosaccharides for improving the bioavailability of iron and preventing or treating of iron deficiency (anaemia), in particular for infants and young children or pregnant women. In another aspect of the invention, the nutritional composition are used for preventing cognitive disorders and/or socio-emotional disorders in an infant and/or young child..
N.v. Nutricia


 Nutritional compositions containing a prebiotic and lactoferrin and uses thereof patent thumbnailNutritional compositions containing a prebiotic and lactoferrin and uses thereof
Provided is a composition and method for modulating serotonergic receptor expression, reducing anxiety-like behavior and stress-induced inflammatory response in a pediatric subject, the method including administering to the pediatric subject a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides. Further provided is a method for reducing constipation in a pediatric subject by providing a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides..
Mead Johnson Nutrition Company


 Modified galactooligosaccharides patent thumbnailModified galactooligosaccharides
The invention relates to a method for making modified galactooligosaccharides comprising the step of enzymatic glycosylation, the modified galactooligosaccharides obtainable by the method and consumable products containing them.. .
Glycom A/s


Treatment of conditions associated with mycotoxin exposure

We describe a composition comprising a non-digestible oligosaccharide for the treatment, prevention or alleviation of a trichothecene mycotoxin exposure associated condition. The non-digestible oligosaccharide may comprise a galactooligosaccharide and/or fructooligosaccharide.
N.v. Nutricia

Nutritional compositions containing a prebiotic and lactoferrin and uses thereof

Provided is a composition and method for modulating serotonergic receptor expression, reducing anxiety-like behavior and stress-induced inflammatory response in a pediatric subject, the method including administering to the pediatric subject a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides. Further provided is a method for reducing constipation in a pediatric subject by providing a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides..
Mead Johnson Nutrition Company

Nutritional compositions containing synergistic combination and uses thereof

A composition and method for enhancing brain development in a pediatric subject, the method including administering to the pediatric subject a nutritional composition having up to about 7 g/100 kcal of a fat or lipid source, wherein the fat or lipid source includes at least about 0.5 mg/100 kcal of milk or non-milk polar lipids; up to about 5 g/100 kcal of a protein source; at least about 15 mg/100 kcal of lactoferrin from a non-human source; about 0.015 g/100 kcal to about 0.15 g/100 kcal of a prebiotic composition including polydextrose and/or galactooligosaccharide; and at least about 5 mg/100 kcal of a source of long chain polyunsaturated fatty acids.. .
Mead Johnson Nutrition Company

Methods for providing sialylated oligosaccharides

The invention relates to a method for providing analogs of human milk oligosaccharides (hmo), in particular oligosaccharides containing terminal sialic acid. The method comprises the steps of: a) providing a source of non-digestible galactooligosaccharides (gos) containing at least two terminally bonded β-linked galactose residues; b) providing a sialic acid donor having (α2-3)-sialylated o-glycans; c) contacting said gos with said sialic acid donor in the presence of an enzyme having trans-sialidase activity in an enzyme reaction mixture; and d) isolating from said enzyme reaction mixture a fraction comprising at least 20 percent by weight of disialylated galactooligosaccharides (di-sia-gos) based on the dry matter..

Composition with synbiotics

Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed.. .

Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract

Disclosed are nutritional compositions including galactooligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, children, and adults for preventing injury and/or improving the healing of the gastrointestinal tract. Additional suitable methods of using the nutritional compositions including the galactooligosaccharides are also disclosed..

Process for preparing a functional fermented milk product with low acidity and containing a low content of lactose and enhanced with galactooligosaccharides and bifidobacterium, and functional fermented milk product prepared therewith

The present invention relates to a process for preparing a functional fermented milk product with low acidity and containing a low content of lactose and enriched with galactooligosaccharide and bifidobacterium, and functional fermented milk product prepared therewith. The process is characterized by converting lactose in milk materials to galactooligosaccharide before subjecting the milk materials to lactic fermentation.

Method for reducing the occurrence on infection in young children

The invention pertains to the use of a composition in reducing the number of infections episodes and the occurrence of infections in young children, said composition comprising: (a) long chain polyunsaturated fatty acids, wherein the amount of arachidonic acid is less than 0.06 gram per 100 gram fatty acid; and comprising, per 100 g fatty acids: (i) 0.3-0.6 gram docosahexaenoic acid; (ii) 0.2-0.4 gram eicosapentaenoic acid; and (b) between 1.5 and 2.5 gram indigestible oligosaccharides per 100 kcal, comprising: (i) 1.4-2 gram short-chain galactooligosaccharides; and (ii) 0.1-0.5 gram long-chain fructopolysaccharides.. .

Boiled sugar sweet comprising non-fructosylated a-galactooligosaccharides

The present invention concerns a hard candy comprising a mixture of sugars composed of glucose and non-fructosylated α-galacto-oligosaccharides in particular proportions. It also concerns a method of manufacturing said candies, as well as the utilization, for manufacturing a hard candy, of a composition that includes the aforementioned mixture..

Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome

The present invention relates to the use of a galactooligosaccharide composition for preventing or reducing the risk of developing metabolic syndrome.. .

Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition

The invention discloses an oligosaccharide mixture derived from cow's milk that can be easily spray dried comprising (a) a soluble oligosaccharide population which is the same as that of soluble oligosaccharides found in cow's milk and (b) β-galactooligosaccharides formed by the action of β-galacotsidase on lactose and the milk oligosaccharides. The mixture having a total monosaccharide content of less than 5% w/v and a lactose:oligosaccharide ratio of less than 20.

Agents to treat/prevent amoebiasis

The invention provides formulations comprising isolated lacto-n-tetraose (lnt) or galactooligosaccharides (gos) or variants, isomers, analogs and derivatives thereof and a pharmaceutically acceptable carrier.. .



Galactooligosaccharide topics:
  • Galactooligosaccharide
  • Prebiotics
  • Gastrointestinal
  • Gastrointestinal Tract
  • Protein Source
  • Galactooligosaccharides
  • Whey Protein
  • Malnutrition
  • Isoleucine


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Galactooligosaccharide for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Galactooligosaccharide with additional patents listed. Browse our RSS directory or Search for other possible listings.


    5.9803

    file didn't exist2393

    479195 - 0 - 41